jili slot 777 no deposit bonus
Opposition fighters are at Damascus’ gates. Who are they and what now?Women’s participation in technology, digital spaces, remains ‘alarmingly low’: PTA
A federal judge ruled Monday that a San José State University volleyball player, who teammates say is transgender, can continue to participate in a volleyball tournament this week. The ruling by Judge S. Kato Crews, an appointee of President Biden to the U.S. District Court in Colorado, comes ahead of the three-day Mountain West Conference in Las Vegas that is set to begin Wednesday. The federal lawsuit filed on behalf of several volleyball players, including former students and a San José State associate head coach, not only sought to ban the player from participating in the tournament but also to rescind wins granted to San José State University’s volleyball team after previous rival teams forfeited matches due to the participation of the transgender player. At least four universities forfeited matches against San José State University following controversy over the player. Blaire Fleming, the student who teammates say is transgender, could not immediately be reached for comment. Fleming, who has been on the team’s roster since 2022, has not spoken publicly about the issue. A spokesperson for San José State University could not immediately be reached for comment. The lawsuit, filed two weeks ago, is the latest in the ongoing debate about transgender athletes, particularly transgender women competing in women’s sports. It comes a month after a video showing a play in which the player is seen spiking a ball, hitting a San Diego State player in the arm and briefly knocking her down. The San Diego State player, Keira Herron, a junior, successfully kept the ball in play with the dig and immediately stood up and smiled. But the play circulated on social media accompanied by claims that the San Diego State player was hit on the head and that the San Jose State player is transgender. President-elect Donald Trump, who has previously referenced the video, said he plans to ban all transgender women from competing in women’s sports. Plaintiffs in the case accused San José State University of recruiting a transgender player and argued that allowing the player to participate in the tournament discriminates against female athletes and deprives them of equal opportunities, including access to playing time and scholarships. In his ruling, Crews said the Mountain West Conference Board of Directors had approved a Transgender Participation Policy in 2022 when the player was also on the roster and because no issues were raised ahead of the tournament, the plaintiffs then failed to meet their burden to show irreparable harm had been caused. “Until the filing of this lawsuit, there was no dispute between the parties over the applicability or enforceability of the [Transgender Participation Policy],” Crews wrote. “Concerning SJSU’s alleged trans teammate, she has been a member of the team since the 2022 season and has played on the team each season since.” “It was not until the spring of 2024, at the earliest, that questions arose from Plaintiffs regarding her gender.”
Banking stocks, long considered major beneficiaries of the government's "value-up" (corporate value enhancement) policies, have been battered by the fallout of the martial law crisis. Over 11 trillion won evaporated from the market capitalization of South Korea’s four largest banks in just three days, with their stock prices plummeting further than the KOSPI index. The sell-off by foreign investors, which saw approximately 2.4 trillion won withdrawn, signals growing unease in the market. With President Yoon Suk Yeol's declaration of martial law escalating into an impeachment crisis, experts suggest that the resulting instability is likely to persist for some time. As of December 8, the KOSPI index closed at 2,428.26, a 0.56% drop from the previous day. Compared to the closing price of 2,500.10 on December 3, just before the declaration of martial law, the index has fallen 2.87%, reflecting the market’s reaction to heightened political uncertainty. The banking sector, a key target of the government’s value-up program, bore the brunt of the decline. The stock prices of the four major banks—KB Financial, Shinhan Financial, Hana Financial, and Woori Financial—plunged over three consecutive days from December 4 to 6, immediately following the martial law declaration. During this period, KB Financial fell 15.7%, Shinhan Financial 9%, Hana Financial 7.88%, and Woori Financial 5.87%, highlighting the sector’s vulnerability to political risk. The combined market capitalization of the four financial giants shed over 11 trillion won in the same timeframe, with individual losses as follows: KB Financial (-6.26 trillion won), Shinhan Financial (-2.57 trillion won), Hana Financial (-1.49 trillion won), and Woori Financial (-750 billion won). Foreign investors’ exodus from banking stocks has been particularly striking. From December 4 to 6, they offloaded a total of 2.37 trillion won worth of shares, including significant stakes in KB Financial (222.4 billion won), Shinhan Financial (93.5 billion won), Hana Financial (40 billion won), and Woori Financial (14.3 billion won). This sell-off in the banking sector far exceeded the overall net foreign outflow of 1.08 trillion won from the KOSPI market during the same period, underscoring the intense pressure on financial stocks. The martial law crisis has cast a shadow over the government’s value-up initiatives. Kim Do-ha, an analyst at Hanwha Investment & Securities, explained, “The sharp decline in bank stocks stems from the expansion of political uncertainty following the declaration and subsequent lifting of martial law, coupled with doubts about the execution of the value-up policy.” Financial institutions have scrambled to restore confidence, with IBK Industrial Bank announcing a plan on December 5 to increase its dividend payout ratio to up to 40%. However, most experts view these measures as insufficient to mitigate the crisis. The outlook for banking stocks remains grim. The crisis has exacerbated a strong-dollar trend, weakening the Korean won and amplifying foreign investor concerns. Analysts believe these factors will continue to weigh on the market in the near term. Kim Ji-won, an analyst at KB Securities, noted, “The political uncertainty has heightened foreign investors’ selling pressure, particularly in financial stocks where foreign ownership is high. As long as the political situation remains unstable, the stock market will likely follow suit.” As the political turmoil unfolds, the banking sector faces a prolonged recovery process, with little optimism for a quick rebound in sight. kimka@chosunbiz.com
Appalachian State hires South Carolina offensive coordinator Dowell Loggains as head coachWALTHAM, Mass. , Nov. 25, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches to target improved efficacy and convenience in the treatment of Inflammatory Bowel Disease ("IBD"), today announced that will participate in a fireside chat and investor meetings at the 7th Annual Evercore ISI HealthCONx Conference. Details of the fireside are as follows: To access this webcast, please visit the "Events & Presentations" page within the Investors section of the Spyre website at ir.spyre.com . An archive of the webcast will be available for replay following the end of the conference. About Spyre Therapeutics Spyre Therapeutics is a clinical-stage biotechnology company that aims to create next-generation inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23. For more information, visit Spyre's website at www.spyre.com . Follow Spyre Therapeutics on social media: @spyretx and LinkedIn View original content to download multimedia: https://www.prnewswire.com/news-releases/spyre-therapeutics-to-participate-in-the-7th-annual-evercore-isi-healthconx-conference-302315865.html SOURCE Spyre Therapeutics, Inc.
Mid-American Conference football goes all in on November weeknights for the TV viewers